We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$315M
AUM Growth
-$1.4M
Cap. Flow
-$10M
Cap. Flow %
-3.17%
Top 10 Hldgs %
26.89%
Holding
480
New
50
Increased
56
Reduced
116
Closed
115

Top Sells

Rank Stock Value
1
UNFI icon
United Natural Foods
UNFI
+$1.46M
2
VFC icon
VF Corp
VFC
+$1.29M
3
ORCL icon
Oracle
ORCL
+$1.18M
4
KNGT
KNIGHT TRANSPORTATION INC
KNGT
+$1.04M
5
CBRE icon
CBRE Group
CBRE
+$969K

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Healthcare 14.37%
3 Industrials 12.71%
4 Consumer Discretionary 12.45%
5 Financials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APOG icon
276
Apogee Enterprises
APOG
$900M
$24K 0.01%
417
HUBS icon
277
HubSpot
HUBS
$10.1B
$24K 0.01%
365
MKC icon
278
McCormick & Company Non-Voting
MKC
$14.1B
$24K 0.01%
486
MRC
279
DELISTED
MRC Global
MRC
$24K 0.01%
1,450
MON
280
DELISTED
Monsanto Co
MON
$24K 0.01%
200
BIDU icon
281
Baidu
BIDU
$37.1B
$23K 0.01%
130
INGN icon
282
Inogen
INGN
$176M
$23K 0.01%
239
WLK icon
283
Westlake Corp
WLK
$9.9B
$23K 0.01%
+350
New +$22.2K
DD
284
DELISTED
Du Pont De Nemours E I
DD
$23K 0.01%
285
GPC icon
285
Genuine Parts
GPC
$18.3B
$22K 0.01%
240
-80
-25% -$7.35K
DIS icon
286
Walt Disney
DIS
$181B
$21K 0.01%
200
FIVE icon
287
Five Below
FIVE
$12.8B
$21K 0.01%
428
VRTX icon
288
Vertex Pharmaceuticals
VRTX
$123B
$21K 0.01%
160
AGN
289
DELISTED
Allergan plc
AGN
$21K 0.01%
85
GIS icon
290
General Mills
GIS
$19.3B
$20K 0.01%
355
KHC icon
291
Kraft Heinz
KHC
$29.6B
$20K 0.01%
239
-427
-64% -$38.7K
RDS.B
292
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$20K 0.01%
375
C icon
293
Citigroup
C
$224B
$19K 0.01%
280
TFC icon
294
Truist Financial
TFC
$64.2B
$19K 0.01%
420
+215
+105% +$9.34K
MCBC
295
DELISTED
Macatawa Bank Corp
MCBC
$19K 0.01%
2,000
GSK icon
296
GSK
GSK
$104B
$18K 0.01%
325
CAH icon
297
Cardinal Health
CAH
$55.7B
$17K 0.01%
+220
New +$16.6K
VALE icon
298
Vale
VALE
$62.6B
$17K 0.01%
+1,900
New +$16.1K
NKE icon
299
Nike
NKE
$62.3B
$16K 0.01%
271
+200
+282% +$10.8K
VGK icon
300
Vanguard FTSE Europe ETF
VGK
$31.1B
$16K 0.01%
+284
New +$15.5K

Similar funds

Arcadia Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Arcadia Investment Management held 480 positions worth $315M, down 0.44% from $317M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Arcadia Investment Management withdrew a net $10M in Q2 2017, closing 115 positions and reducing 116 holdings. Its most notable exit was ZELTIQ Aesthetics, Inc., an estimated $98K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Arcadia Investment Management opened a new position in Schwab US Large- Cap ETF worth $583K.

  • Arcadia Investment Management's largest Q2 2017 buy was Schwab US Large- Cap ETF: 60,540 shares worth $583K.
  • Arcadia Investment Management added most to Monolithic Power Systems in Q2 2017, an estimated $2.33M increase.
  • Arcadia Investment Management's biggest Q2 2017 reduction was United Natural Foods, cutting an estimated $1.46M.
  • Arcadia Investment Management fully exited ZELTIQ Aesthetics, Inc. in Q2 2017, selling an estimated $98K.
  • Arcadia Investment Management's ten largest holdings make up 27% of its $315M portfolio in Q2 2017.
  • Arcadia Investment Management opened 50 new positions and closed 115 in Q2 2017.
  • Arcadia Investment Management's portfolio value fell 0.44% quarter-over-quarter to $315M.

Based on Arcadia Investment Management's 13F filing for Q2 2017, filed 3 Aug 2017.